MOLLIE DILBECK: Open Payments
NPI 1710498233 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 21 payments from 10 companies in 2025. Trend: 2023 $615 · 2024 $416 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Amgen Inc. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $26 |
| CVRx, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: LEQVIO, JARDIANCE, WINREVAIR, Kerendia, REPATHA, LifeVest, Barostim Neo System, CAMZYOS.
Industry payments across OK — which companies pay providers there.
